Gene |
Time course graph |
Description |
Treatment |
15min |
30min |
1min |
2min |
4min |
8min |
20min |
Ch25h | | cholesterol 25-hydroxylase (Ch25h), mRNA [NM_009890] |
KLA | 11.10 |
11.52 |
17.64 |
19.84 |
9.53 |
5.76 |
0.63 |
| ATP | 1.63 |
1.73 |
2.93 |
3.18 |
4.70 |
2.08 |
0.09 |
| ATP+KLA | 10.54 |
12.32 |
25.05 |
31.45 |
23.23 |
8.11 |
0.78 |
|
Cyp51 | | cytochrome P450, family 51 (Cyp51), mRNA [NM_020010] |
KLA | 1.05 |
1.08 |
1.11 |
0.93 |
0.82 |
0.50 |
0.52 |
| ATP | 1.01 |
1.07 |
1.27 |
1.22 |
0.98 |
0.75 |
1.09 |
| ATP+KLA | 1.06 |
1.10 |
1.09 |
1.03 |
0.72 |
0.44 |
0.39 |
|
Dhcr24 | | 24-dehydrocholesterol reductase (Dhcr24), mRNA [NM_053272] |
KLA | 0.50 |
0.50 |
0.43 |
0.41 |
0.34 |
0.28 |
0.36 |
| ATP | 1.09 |
1.12 |
1.01 |
1.08 |
0.72 |
0.43 |
1.04 |
| ATP+KLA | 0.51 |
0.54 |
0.46 |
0.54 |
0.33 |
0.21 |
0.18 |
|
Dhcr7 | | 7-dehydrocholesterol reductase (Dhcr7), mRNA [NM_007856] |
KLA | 0.57 |
0.54 |
0.52 |
0.48 |
0.39 |
0.47 |
0.70 |
| ATP | 1.00 |
1.08 |
1.17 |
1.19 |
0.70 |
0.39 |
0.74 |
| ATP+KLA | 0.58 |
0.56 |
0.57 |
0.64 |
0.47 |
0.45 |
0.32 |
|
Ebp | | phenylalkylamine Ca2+ antagonist (emopamil) binding protein (Ebp), mRNA [NM_007898] |
KLA | 0.77 |
0.75 |
0.66 |
0.77 |
0.61 |
0.71 |
0.67 |
| ATP | 0.83 |
0.83 |
1.15 |
0.99 |
0.88 |
0.83 |
0.95 |
| ATP+KLA | 0.67 |
0.72 |
0.95 |
0.79 |
0.86 |
0.75 |
0.74 |
|
Fdft1 | | farnesyl diphosphate farnesyl transferase 1 (Fdft1), mRNA [NM_010191] |
KLA | 0.96 |
0.98 |
0.97 |
0.99 |
0.88 |
0.78 |
0.77 |
| ATP | 1.00 |
1.01 |
1.08 |
1.10 |
0.93 |
1.02 |
1.28 |
| ATP+KLA | 0.98 |
0.97 |
0.98 |
1.04 |
0.97 |
0.87 |
0.73 |
|
Fdps | | 13 days embryo male testis cDNA, RIKEN full-length enriched library, clone:6030492I17 product:farnesyl diphosphate synthetase, full insert sequence. [AK077979] |
KLA | 0.76 |
0.79 |
0.79 |
0.69 |
0.65 |
0.37 |
0.49 |
| ATP | 0.63 |
0.70 |
0.85 |
0.30 |
0.46 |
0.89 |
0.86 |
| ATP+KLA | 0.54 |
0.52 |
0.63 |
0.39 |
0.42 |
0.40 |
0.31 |
|
Fdps | | farnesyl diphosphate synthetase (Fdps), mRNA [NM_134469] |
KLA | 0.87 |
0.93 |
0.89 |
0.97 |
0.76 |
0.43 |
0.48 |
| ATP | 1.12 |
1.10 |
1.05 |
1.23 |
1.05 |
0.60 |
0.88 |
| ATP+KLA | 0.93 |
0.99 |
1.00 |
1.02 |
0.70 |
0.45 |
0.33 |
|
Ggps1 | | adult male spinal cord cDNA, RIKEN full-length enriched library, clone:A330064P13 product:geranylgeranyl diphosphate synthase 1, full insert sequence [AK138564] |
KLA | 1.17 |
1.19 |
1.22 |
1.09 |
1.12 |
1.25 |
1.22 |
| ATP | 1.02 |
1.06 |
0.90 |
0.91 |
1.06 |
1.11 |
0.92 |
| ATP+KLA | 1.23 |
1.10 |
1.10 |
1.19 |
1.22 |
1.09 |
0.89 |
|
Ggps1 | | geranylgeranyl diphosphate synthase 1 (Ggps1), mRNA [NM_010282] |
KLA | 1.17 |
1.17 |
1.29 |
1.28 |
1.22 |
1.57 |
1.73 |
| ATP | 0.88 |
0.84 |
0.98 |
0.85 |
0.96 |
2.02 |
2.04 |
| ATP+KLA | 1.08 |
1.09 |
1.33 |
1.11 |
1.23 |
1.95 |
2.71 |
|
Hmgcr | | 3-hydroxy-3-methylglutaryl-Coenzyme A reductase (Hmgcr), mRNA [NM_008255] |
KLA | 2.15 |
2.09 |
2.02 |
1.44 |
1.13 |
0.88 |
1.02 |
| ATP | 1.05 |
1.16 |
1.43 |
1.53 |
1.83 |
2.60 |
1.87 |
| ATP+KLA | 2.16 |
2.23 |
1.99 |
1.81 |
1.34 |
1.81 |
1.78 |
|
Hmgcs2 | | 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 (Hmgcs2), nuclear gene encoding mitochondrial protein, mRNA [NM_008256] |
KLA | 0.92 |
1.10 |
1.00 |
0.99 |
1.08 |
1.06 |
1.14 |
| ATP | 0.99 |
1.02 |
1.00 |
1.00 |
0.98 |
1.08 |
0.92 |
| ATP+KLA | 0.99 |
1.00 |
1.00 |
1.03 |
1.28 |
1.06 |
1.00 |
|
Hsd17b7 | | hydroxysteroid (17-beta) dehydrogenase 7 (Hsd17b7), mRNA [NM_010476] |
KLA | 0.87 |
0.86 |
0.78 |
0.84 |
0.86 |
0.76 |
0.77 |
| ATP | 1.05 |
0.94 |
1.22 |
0.86 |
0.69 |
0.67 |
1.48 |
| ATP+KLA | 0.88 |
0.76 |
0.91 |
0.69 |
0.53 |
0.34 |
0.36 |
|
Idi1 | | isopentenyl-diphosphate delta isomerase (Idi1), transcript variant 2, mRNA [NM_177960] |
KLA | 1.43 |
1.49 |
1.51 |
1.22 |
0.89 |
0.45 |
0.52 |
| ATP | 1.01 |
1.06 |
1.43 |
1.31 |
0.85 |
0.62 |
1.15 |
| ATP+KLA | 1.36 |
1.35 |
1.52 |
1.45 |
0.84 |
0.35 |
0.32 |
|
Lss | | adult male brain UNDEFINED_CELL_LINE cDNA, RIKEN full-length enriched library, clone:M5C1106O04 product:lanosterol synthase, full insert sequence [AK147680] |
KLA | 0.52 |
0.46 |
0.46 |
0.47 |
0.49 |
0.43 |
0.44 |
| ATP | 0.93 |
0.92 |
1.44 |
0.97 |
0.55 |
0.39 |
0.46 |
| ATP+KLA | 0.46 |
0.45 |
0.56 |
0.47 |
0.44 |
0.32 |
0.15 |
|
Lss | | lanosterol synthase (Lss), mRNA [NM_146006] |
KLA | 0.77 |
0.80 |
0.87 |
0.80 |
0.90 |
0.69 |
0.80 |
| ATP | 1.04 |
1.08 |
1.03 |
1.18 |
0.73 |
0.67 |
1.62 |
| ATP+KLA | 0.79 |
0.89 |
0.86 |
0.88 |
0.56 |
0.46 |
0.42 |
|
Mvd | | mevalonate (diphospho) decarboxylase (Mvd), mRNA [NM_138656] |
KLA | 0.53 |
0.53 |
0.53 |
0.53 |
0.54 |
0.48 |
0.81 |
| ATP | 0.95 |
0.97 |
1.05 |
1.29 |
1.06 |
0.87 |
1.80 |
| ATP+KLA | 0.54 |
0.57 |
0.60 |
0.73 |
0.77 |
0.56 |
0.47 |
|
Mvk | | mevalonate kinase (Mvk), mRNA [NM_023556] |
KLA | 0.87 |
0.90 |
0.89 |
0.91 |
0.90 |
0.94 |
0.98 |
| ATP | 0.91 |
0.79 |
0.56 |
0.58 |
0.35 |
0.47 |
1.40 |
| ATP+KLA | 0.89 |
0.73 |
0.56 |
0.60 |
0.42 |
0.42 |
0.65 |
|
Nsdhl | | NAD(P) dependent steroid dehydrogenase-like (Nsdhl), mRNA [NM_010941] |
KLA | 0.98 |
1.05 |
1.03 |
0.95 |
0.97 |
0.87 |
0.89 |
| ATP | 1.02 |
1.16 |
1.11 |
1.33 |
0.91 |
0.57 |
1.05 |
| ATP+KLA | 1.08 |
1.02 |
0.86 |
1.20 |
0.77 |
0.58 |
0.47 |
|
Nsdhl | | activated spleen cDNA, RIKEN full-length enriched library, clone:F830111P16 product:unclassifiable, full insert sequence [AK156993] |
KLA | 1.05 |
0.94 |
0.94 |
0.88 |
1.08 |
0.85 |
0.76 |
| ATP | 1.14 |
1.03 |
1.03 |
0.75 |
0.74 |
0.92 |
1.02 |
| ATP+KLA | 1.04 |
0.98 |
0.92 |
0.70 |
0.84 |
0.70 |
0.76 |
|
Pmvk | | phosphomevalonate kinase (Pmvk), mRNA [NM_026784] |
KLA | 0.89 |
0.91 |
0.96 |
0.99 |
0.92 |
0.78 |
0.88 |
| ATP | 1.12 |
0.97 |
1.07 |
1.10 |
0.70 |
0.51 |
1.19 |
| ATP+KLA | 0.94 |
0.94 |
1.05 |
0.91 |
0.80 |
0.44 |
0.53 |
|
Sc4mol | | sterol-C4-methyl oxidase-like (Sc4mol), mRNA [NM_025436] |
KLA | 0.43 |
0.37 |
0.41 |
0.44 |
0.44 |
0.41 |
0.54 |
| ATP | 0.95 |
0.92 |
1.30 |
0.92 |
0.70 |
0.47 |
1.36 |
| ATP+KLA | 0.41 |
0.37 |
0.45 |
0.38 |
0.35 |
0.23 |
0.37 |
|
Sc5d | | 10 days neonate cortex cDNA, RIKEN full-length enriched library, clone:A830073K23 product:unclassifiable, full insert sequence [AK080673] |
KLA | 0.62 |
0.56 |
0.53 |
0.46 |
0.38 |
0.29 |
0.35 |
| ATP | 0.87 |
0.91 |
1.37 |
0.86 |
0.56 |
0.43 |
0.33 |
| ATP+KLA | 0.54 |
0.49 |
0.72 |
0.72 |
0.72 |
0.39 |
0.20 |
|
Sc5d | | sterol-C5-desaturase (fungal ERG3, delta-5-desaturase) homolog (S. cerevisae) (Sc5d), mRNA [NM_172769] |
KLA | 1.18 |
1.19 |
1.17 |
1.08 |
0.94 |
0.63 |
0.70 |
| ATP | 0.99 |
1.00 |
1.31 |
1.09 |
0.83 |
1.04 |
1.51 |
| ATP+KLA | 1.08 |
1.07 |
1.29 |
1.20 |
1.04 |
0.88 |
0.76 |
|
Soat1 | | sterol O-acyltransferase 1 (Soat1), mRNA [NM_009230] |
KLA | 0.68 |
0.68 |
0.62 |
0.63 |
0.59 |
0.84 |
1.33 |
| ATP | 1.06 |
1.16 |
1.02 |
1.10 |
0.92 |
0.79 |
1.51 |
| ATP+KLA | 0.72 |
0.71 |
0.57 |
0.72 |
0.64 |
0.66 |
1.29 |
|
Soat2 | | sterol O-acyltransferase 2 (Soat2), mRNA [NM_146064] |
KLA | 1.03 |
0.91 |
1.03 |
1.07 |
1.52 |
1.83 |
2.92 |
| ATP | 0.97 |
0.99 |
1.06 |
0.84 |
0.81 |
0.93 |
2.17 |
| ATP+KLA | 0.99 |
0.93 |
1.01 |
0.94 |
0.94 |
1.07 |
2.74 |
|
Sqle | | squalene epoxidase (Sqle), mRNA [NM_009270] |
KLA | 0.41 |
0.38 |
0.35 |
0.27 |
0.26 |
0.24 |
0.42 |
| ATP | 1.00 |
1.02 |
1.10 |
0.92 |
0.83 |
0.65 |
1.37 |
| ATP+KLA | 0.43 |
0.42 |
0.32 |
0.31 |
0.26 |
0.23 |
0.31 |
|
Tm7sf2 | | transmembrane 7 superfamily member 2 (Tm7sf2), mRNA [NM_028454] |
KLA | 0.93 |
0.90 |
0.79 |
0.88 |
0.63 |
0.52 |
0.33 |
| ATP | 0.84 |
0.94 |
0.97 |
1.03 |
0.76 |
0.60 |
0.51 |
| ATP+KLA | 0.82 |
0.94 |
0.90 |
0.95 |
0.67 |
0.47 |
0.27 |
|